MTG Salvation

Quote from Ryperior74 »

But you got to understand That’s not what I meant by the “it’s like chicken pox” I meant you get it only one time and you will never get it again not what the disease is like, I apologize if I said my first comment the wrong way I meant it as concept (if that’s right)

I’m just glad you survived it and that probably your worst fear

What studies have you read indicating that? Even the more optimistic studies I've read said that researchers are hoping covid-19 is like chicken pox (in the "get it once, immune for life" aspect), but that it's likelier that it'll fall in the grey zone that the coronavirus family tends to inhabit: that people who contract the virus can develop antibodies that make them immune to the virus, but that antibody creation may not be equivalent in all patients and that those antibodies may only last a period of time rather than indefinitely. Research on covid-19 has, to me at least, seemed to have uncovered nothing conclusive.

This article in Scientific American is a great read, and lays out the complications and nuance in covid immunity, antibodies, etc.

It is less clear what those antibody tests mean for real life, however, because immunity functions on a continuum. With some pathogens, such as the varicella-zoster virus (which causes chicken pox), infection confers near-universal, long-lasting resistance. Natural infection with Clostridium tetani, the bacterium that causes tetanus, on the other hand, offers no protection—and even people getting vaccinated for it require regular booster shots. On the extreme end of this spectrum, individuals infected with HIV often have large amounts of antibodies that do nothing to prevent or clear the disease.

At this early stage of understanding the new coronavirus, it is unclear where COVID-19 falls on the immunity spectrum. Although most people with SARS-CoV-2 seem to produce antibodies, “we simply don’t know yet what it takes to be effectively protected from this infection,” says Dawn Bowdish, a professor of pathology and molecular medicine and Canada Research Chair in Aging and Immunity at McMaster University in Ontario. Researchers are scrambling to answer two questions: How long do SARS-CoV-2 antibodies stick around? And do they protect against reinfection?

Immunity to seasonal coronaviruses (such as those that cause common colds), for example, starts declining a couple of weeks after infection. And within a year, some people are vulnerable to reinfection. That observation is disconcerting when experts say it is unlikely we will have a vaccine for COVID-19 within 18 months. But studies of SARS-CoV—the virus that causes severe acute respiratory syndrome, or SARS, which shares a considerable amount of its genetic material with SARS-CoV-2—are more promising. Antibody testing shows SARS-CoV immunity peaks at around four months and offers protection for roughly two to three years. As Preeti Malani, chief health officer and a professor of medicine at the University of Michigan, said in a video interview with JAMA Editor in Chief Howard Bauchner,this period presents “a pretty good time line for thinking about vaccines and therapeutics” for COVID-19.

All of this is complicated further by reports of 141 people in South Korea who had recovered from covid-19 but are now testing positive again (either from re-infection or relapse, neither of which is good for us), indicators that not everyone who contracts covid-19 produce enough antibodies to be immune past recovery, and that any remote chance of herd immunity is a very long way away.

I'm not sure who told you that covid-19 recovery results in permanent immunity, but that is absolutely not proven at this point. In fairness, it could be true, but it is unlikely given the typical nature of coronaviruses and the early indications from research.

Helpful video between Tolarian Community College and MaRo:

https://youtu.be/vVrwnCNiqY8

Quote from OrzhovPlaneswalker »

Helpful video between Tolarian Community College and MaRo:

https://youtu.be/vVrwnCNiqY8

Thank you for sharing. Like I said in the other thread, I think this is largely MaRo delivering platitudes, but it's meaningful that they're posturing continued support for paper. I guess my question is: if they plan on releasing everything in paper, do they not expect a drop in sales given the lack of events, LGS play, most groups meeting, etc? Are they betting on demand remaining constant?

I got a notice today from CoolstuffInc that Commander 2020 is limited/delayed and so my pre-order won't go out on the 15th. I don't know how far this is and haven't seen anything from WotC on the subject (recently), though the email indicates that WotC announced this delay.

Wizards of the Coast has announced that there have been delays in the manufacturing and delivery of these items, resulting in a massive reduction in our allocation of product.

I'm checking with my local FLGS who just re-opened online ordering, so I'll probably swap over to them. The only reason I went with CSI was price and the fact that they were taking orders when the FLGS was not.